Simple jQuery Dropdowns
Please use this identifier to cite or link to this item: http://repository.li.mahidol.ac.th/dspace/handle/123456789/46665
Title: Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an observational study of a regional elimination programme
Authors: Jordi Landier
Daniel M. Parker
Aung Myint Thu
Khin Maung Lwin
Gilles Delmas
François H. Nosten
Chiara Andolina
Ricardo Aguas
Saw Moe Ang
Ei Phyo Aung
Naw Baw Baw
Saw Aye Be
Saw B'Let
Hay Bluh
Craig A. Bonnington
Victor Chaumeau
Miasa Chirakiratinant
Win Cho Cho
Peter Christensen
Vincent Corbel
Nicholas PJ Day
Saw Hsa Dah
Mehul Dhorda
Arjen M. Dondorp
Jean Gaudart
Gornpan Gornsawun
Warat Haohankhunnatham
Saw Kyaw Hla
Saw Nay Hsel
Gay Nay Htoo
Saw Nay Htoo
Mallika Imwong
Saw John
Ladda Kajeechiwa
Lily Kereecharoen
Praphan Kittiphanakun
Keerati Kittitawee
Kamonchanok Konghahong
Saw Diamond Khin
Saw Win Kyaw
Clare Ling
Khine Shwe War Lwin
Naw K’ Yin Ma
Alexandra Marie
Cynthia Maung
Ed Marta
Myo Chit Minh
Olivo Miotto
Paw Khu Moo
Ku Ler Moo
Merry Moo
Naw Na Na
Mar Nay
Suphak Nosten
Slight Naw Nyo
Eh Kalu Shwe Oh
Phu Thit Oo
Tun Pyit Oo
Daniel M. Parker
Eh Shee Paw
Choochai Phumiya
Aung Pyae Phyo
Kasiha Pilaseng
Stéphane Proux
Santisuk Rakthinthong
Wannee Ritwongsakul
Kloloi Salathibuphha
Armon Santirad
Sunisa Sawasdichai
Lorenz von Seidlein
Paw Wah Shee
Paw Bway Shee
Decha Tangseefa
May Myo Thwin
Saw Win Tun
Chode Wanachaloemlep
Lisa J. White
Nicholas J. White
Jacher Wiladphaingern
Saw Nyunt Win
Nan Lin Yee
Daraporn Yuwapan
Sciences Economiques et Sociales de la Santé et Traitement de l'Information Médicale
Mahidol University
Nuffield Department of Clinical Medicine
University of California, Irvine
Keywords: Medicine
Issue Date: 12-May-2018
Citation: The Lancet. Vol.391, No.10133 (2018), 1916-1926
Abstract: © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Background: Potentially untreatable Plasmodium falciparum malaria threatens the Greater Mekong subregion. A previous series of pilot projects in Myanmar, Laos, Cambodia, and Vietnam suggested that mass drug administration was safe, and when added to provision of early diagnosis and treatment, could reduce the reservoir of P falciparum and interrupts transmission. We examined the effects of a scaled-up programme of this strategy in four townships of eastern Myanmar on the incidence of P falciparum malaria. Methods: The programme was implemented in the four townships of Myawaddy, Kawkareik, Hlaingbwe, and Hpapun in Kayin state, Myanmar. Increased access to early diagnosis and treatment of malaria was provided to all villages through community-based malaria posts equipped with rapid diagnostic tests, and treatment with artemether–lumefantrine plus single low-dose primaquine. Villages were identified as malarial hotspots (operationally defined as >40% malaria, of which 20% was P falciparum) with surveys using ultrasensitive quantitative PCR either randomly or targeted at villages where the incidence of clinical cases of P falciparum malaria remained high (ie, >100 cases per 1000 individuals per year) despite a functioning malaria post. During each survey, a 2 mL sample of venous blood was obtained from randomly selected adults. Hotspots received targeted mass drug administration with dihydroartemisinin–piperaquine plus single-dose primaquine once per month for 3 consecutive months in addition to the malaria posts. The main outcome was the change in village incidence of clinical P falciparum malaria, quantified using a multivariate, generalised, additive multilevel model. Malaria prevalence was measured in the hotspots 12 months after mass drug administration. Findings: Between May 1, 2014, and April 30, 2017, 1222 malarial posts were opened, providing early diagnosis and treatment to an estimated 365 000 individuals. Incidence of P falciparum malaria decreased by 60 to 98% in the four townships. 272 prevalence surveys were undertaken and 69 hotspot villages were identified. By April 2017, 50 hotspots were treated with mass drug administration. Hotspot villages had a three times higher incidence of P falciparum at malarial posts than neighbouring villages (adjusted incidence rate ratio [IRR] 2·7, 95% CI 1·8–4·4). Early diagnosis and treatment was associated with a significant decrease in P falciparum incidence in hotspots (IRR 0·82, 95% CI 0·76–0·88 per quarter) and in other villages (0·75, 0·73–0·78 per quarter). Mass drug administration was associated with a five-times decrease in P falciparum incidence within hotspot villages (IRR 0·19, 95% CI 0·13–0·26). By April, 2017, 965 villages (79%) of 1222 corresponding to 104 village tracts were free from P falciparum malaria for at least 6 months. The prevalence of wild-type genotype for K13 molecular markers of artemisinin resistance was stable over the three years (39%; 249/631). Interpretation: Providing early diagnosis and effective treatment substantially decreased village-level incidence of artemisinin-resistant P falciparum malaria in hard-to-reach, politically sensitive regions of eastern Myanmar. Targeted mass drug administration significantly reduced malaria incidence in hotspots. If these activities could proceed in all contiguous endemic areas in addition to standard control programmes already implemented, there is a possibility of subnational elimination of P falciparum. Funding: The Bill & Melinda Gates Foundation, the Regional Artemisinin Initiative (Global Fund against AIDS, Tuberculosis and Malaria), and the Wellcome Trust.
URI: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85046171115&origin=inward
http://repository.li.mahidol.ac.th/dspace/handle/123456789/46665
ISSN: 1474547X
01406736
Appears in Collections:Scopus 2018

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.